Nurix Therapeutics, Inc. (NRIX) insider trading.
In Q3 2026, insiders at Nurix Therapeutics, Inc. reported 28 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $1.4M.
- Transactions
- 28
- Purchases (P)
- 0
- Sales (S)
- 13
- Net shares, P minus S
- -58,603
- Insiders
- 3
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Ring Christine | Officer · Chief Legal Officer | 12 | 0 | 5 |
| Hansen Gwenn | Officer · Chief Scientific Officer | 10 | 0 | 5 |
| van Houte Hans | Officer · Chief Financial Officer | 6 | 0 | 3 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Ring Christine | M (A) | 5,787 | $8.72 | 14,897 | Form 4 |
| 2026-09-02 | Ring Christine | S (D) | 400 | $26.64 | 9,110 | Form 4 |
| 2026-09-02 | Ring Christine | S (D) | 5,387 | $25.69 | 9,510 | Form 4 |
| 2026-09-01 | Hansen Gwenn | S (D) | 1,452 | $25.47 | 117,227 | Form 4 |
| 2026-09-01 | Hansen Gwenn | M (A) | 1,452 | $1.86 | 118,679 | Form 4 |
| 2026-08-05 | Hansen Gwenn | S (D) | 4,356 | $25 | 117,227 | Form 4 |
| 2026-08-05 | Hansen Gwenn | M (A) | 4,356 | $1.86 | 121,583 | Form 4 |
| 2026-08-04 | Hansen Gwenn | S (D) | 2,611 | $24.64 | 117,227 | Form 4 |
| 2026-08-04 | Hansen Gwenn | S (D) | 1,500 | $23.87 | 119,838 | Form 4 |
| 2026-08-04 | van Houte Hans | S (D) | 1,794 | $23.89 | 43,133 | Form 4 |
| 2026-08-04 | van Houte Hans | S (D) | 2,967 | $24.65 | 40,166 | Form 4 |
| 2026-08-03 | Ring Christine | S (D) | 16,589 | $23.05 | 9,110 | Form 4 |
| 2026-08-03 | Ring Christine | M (A) | 5,787 | $8.72 | 25,699 | Form 4 |
| 2026-07-30 | Hansen Gwenn | M (A) | 3,572 | $0 | 125,185 | Form 4 |
| 2026-07-30 | Hansen Gwenn | S (D) | 3,847 | $23.38 | 121,338 | Form 4 |
| 2026-07-30 | Hansen Gwenn | M (A) | 2,858 | $0 | 121,613 | Form 4 |
| 2026-07-30 | Hansen Gwenn | M (A) | 3,750 | $0 | 118,755 | Form 4 |
| 2026-07-30 | Ring Christine | M (A) | 3,572 | $0 | 23,759 | Form 4 |
| 2026-07-30 | Ring Christine | M (A) | 2,858 | $0 | 20,187 | Form 4 |
| 2026-07-30 | Ring Christine | M (A) | 3,750 | $0 | 17,329 | Form 4 |
| 2026-07-30 | Ring Christine | S (D) | 3,847 | $23.38 | 19,912 | Form 4 |
| 2026-07-30 | van Houte Hans | M (A) | 3,750 | $0 | 41,342 | Form 4 |
| 2026-07-30 | van Houte Hans | S (D) | 2,845 | $23.38 | 44,927 | Form 4 |
| 2026-07-30 | van Houte Hans | M (A) | 3,572 | $0 | 47,772 | Form 4 |
| 2026-07-30 | van Houte Hans | M (A) | 2,858 | $0 | 44,200 | Form 4 |
| 2026-07-02 | Ring Christine | S (D) | 11,008 | $23.56 | 13,579 | Form 4 |
| 2026-07-02 | Ring Christine | M (A) | 5,787 | $8.72 | 24,587 | Form 4 |
| 2026-07-02 | Ring Christine | M (A) | 5,221 | $1.86 | 18,800 | Form 4 |
Transaction codes in this quarter
Get NRIX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1549595&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NRIX company page · Nurix Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Nurix Therapeutics, Inc. (NRIX)?
In Q3 2026, insiders at Nurix Therapeutics, Inc. reported 28 non-derivative transactions on 10 Forms 3, 4 and 5: 0 open-market purchases and 13 sales worth $1.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Nurix Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nrix.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.